TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA

Kalyoncu, U.Bilgin, E.Erden, A.Satis, H.Tufan, A.Tekgoz, E.Ates, A.2024-09-182024-09-1820210003-49671468-2060https://doi.org/10.1136/annrheumdis-2021-eular.1236https://hdl.handle.net/20.500.12483/13013Annual European Congress of Rheumatology (EULAR) -- JUN 02-05, 2021 -- ELECTR NETWORK[Abstract Not Available]eninfo:eu-repo/semantics/openAccessTOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATAConference Object80697010.1136/annrheumdis-2021-eular.1236WOS:000692629300123Q1